Ipca Laboratories shares are currently trading at ₹1,520.00, up by 1.01% as the company prepares to announce its second-quarter earnings.
With a total market cap of ₹38,512.30 crore, the stock’s 52-week high is ₹1,708.65, and the low is ₹1,041.00. Investors are keeping a close eye on the pharmaceutical company’s financial performance in anticipation of its Q2 report.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Au
